OMOP

OHDSI national nodes: helping to strengthen research collaboration across Europe Interview with Renske Los, Erasmus Medical Center, Rotterdam

by

  Renske Los is assistant professor at the department of Medical Informatics, Erasmus Medical Center in Rotterdam, the Netherlands, and co-lead of OHDSI NL. Together with Prof. Peter Rijnbeek she helps onboard new national nodes to the OHDSI Europe chapter. How do national nodes evolve and why are they important? Since 2021, national nodes have … Read more

OHDSI Global Symposium, Rockville, Maryland US, 14-16th October 2022

by

EHDEN colleagues were delighted to participate and present at this year’s OHDSI Symposium, the first in person following the COVID-19 lockdowns. With more than 400 colleagues from around the world, the three days were split into a whole day conference, an all-day tutorial and then work group meetings and exposure of these to OHDSI colleagues. … Read more

EHDEN/OHDSI Feature in COVID-19 Real-World Evidence Primer

by

COVID-19 was declared a pandemic by the WHO in March of 2020 and EHDEN was formally launched in November 2018. With a solid foundation of Data Partners in place by early 2020, and since then, EHDEN has been collaborating with OHDSI (Observational Health Data Science and Informatics), our growing base of Data Partners, and other … Read more

BLOG – The PIONEER study-a-thon: how EHDEN collaborates with its sister projects to generate medical evidence

by

No one is big enough alone to master the complex future. Curious minds could help here in learning from others and building on accomplished work. It seems that even politicians and decision makers are sharing the same mindset: bringing in more cohesion and bridging different aspirations together is the efficient way forward. Ecosystems and collaboration are the keys for sustainable future despite of the differences.

EHDEN Finalises its 3rd Open Call Process for SMEs, accelerating the realisation of the federated health data network

by

The European Health Data & Evidence Network (EHDEN) recently completed its 3rd open call for SMEs (Small & Medium-sized Enterprises), paving the way for an acceleration in mapping health data from various formats and institutions to the OMOP common data model. This will ultimately result in a Europe that more smartly manages and utilises healthcare … Read more

Uncovering the natural history of prostate cancer in data from millions of patient lives across the globe

by

PIONEER, EHDEN and OHDSI join forces to study the clinical management of prostate cancer in a virtual studyathon Prostate cancer is a major disease affecting more than 2 million men in Europe alone, and has now become the most common cancer in men. Clinical management of this complex disease is challenging and involves difficult trade-offs, … Read more

EHDEN publication in PharmacoEconomics – utility of the OMOP CDM in Health Technology Assessment

by

25th January, Brussels, Belgium. EHDEN is delighted that our colleagues in WP2, led by our Partner the National Institute for Health & Clinical Excellence (NICE), have published in PharmacoEconomics in December 2020. Entitled, ‘Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology Assessment’, the authors explore the applicability of the OMOP CDM to HTA … Read more

EHDEN delighted to announce Prof Dani Prieto-Alhambra, Project Research Coordinator, elected member of ENCePP Steering Group.

by

11 December 2020, Brussels, Belgium. Prof Prieto-Alhambra, MD, MSc (Oxf), PhD, Professor of Pharmaco- and Device Epidemiology, University of Oxford, UK, has been elected to the Steering Group of the European Network of Centres for Pharmaoepidemiology and Pharmacovigilance (ENCePP). The ENCePP Steering Group was established in 2010 to oversee the mid to long-term implementation of … Read more

EHDEN 2020 Webinar Series – The Need for Health Data in the Era of COVID-19: Full Report

by

10 December 2020, Brussels, Belgium. The European Health Data and Evidence Network (EHDEN) is a pan-European public-private partnership of 22 organisations, led by Erasmus Medical Center and Janssen Pharmaceutica, whose mission is to make large-scale analysis of health data in Europe a reality. Under the aegis of the EU´s Innovative Medicines Initiative and scheduled to run … Read more